ABC News

Preliminary Clinical Results Showed First-Time Gains in Dementia Treatment

A pill once used as an antihistamine in Russia has shown a slight but unique promise for treating Alzheimer's disease and is now on a fast track to drug studies in the United States. The drug, called Dimebon, appeared to slow memory loss in patients with mild to moderate Alzheimer's disease. But, unlike current Alzheimer's therapies, Dimebon also slightly improved memory. In another first, Dimebon's effect continued for more than a year, while current Alzheimer's treatments are known to peak... Full Story
Contribute | Do you have more information about this topic? If so, please click here to contact the editors of ABC News.
6 Comments | Add Yours
Comments that include profanity, personal attacks, or antisocial behavior such as "spamming," "trolling," or any other inappropriate material will be removed from the site. We will take steps to block users who violate any of our terms of use. You are fully responsible for the content you post.
 
Click Here